Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Am J Obstet Gynecol. 2015 Aug 7;213(5):668.e1–668.e10. doi: 10.1016/j.ajog.2015.08.002

Table 3.

Total number of cells and percent surface marker postive cells in a 20× field.

Treatment
(Gynemesh)
Total Number of
Cells (per 20×
field)

% of Positive
Cells (per 20×
field)

CD45 514±121 21.4±5.4
CD68 510±108 c10.5±3.9
CD3 510±114 d7.3±1.7
CD20 509±109 3.0±1.2
CD117 508±121 0.2±0.2
P value 1.00a <0.001b
a

Comparison of p-value among groups, significant difference if p<0.05;

b

Comparison between CD68, CD3, CD20, and CD117,

c

Significance seen between CD68 and CD20 and CD68 and CD117;

d

Significance seen between CD3 and CD20 and CD3 and CD117.